share_log

雲頂新耀-B：非執行董事變更

EVEREST MED-B: CHANGE OF NON-EXECUTIVE DIRECTOR

香港交易所 ·  Feb 9 02:48
Summary by Moomoo AI
雲頂新耀-B（云顶新耀）宣布董事會變動，龔聿波先生已於2024年2月9日辭去非執行董事職務，並無與董事會意見分歧或其他需告知股東及聯交所的事項。同日，馮洪剛先生獲委任為新的非執行董事，馮先生在醫療行業擁有超過35年經驗，曾任職於CBC集團及先聲藥業集團有限公司等。馮先生的委任為期三年，期間不會收取薪酬，但可報銷相關費用。
雲頂新耀-B（云顶新耀）宣布董事會變動，龔聿波先生已於2024年2月9日辭去非執行董事職務，並無與董事會意見分歧或其他需告知股東及聯交所的事項。同日，馮洪剛先生獲委任為新的非執行董事，馮先生在醫療行業擁有超過35年經驗，曾任職於CBC集團及先聲藥業集團有限公司等。馮先生的委任為期三年，期間不會收取薪酬，但可報銷相關費用。
Genting Xinyao-B (Genting Xinyao) announces the change of Board of Directors. Mr. Gong Yubo has resigned as a non-executive director on February 9, 2024, without disagreement with the Board's views or other matters to be notified to shareholders and the Exchange. On the same day, Mr. Fung Hong Kong was appointed as the new non-executive director. Mr. Fung has more than 35 years of experience in the medical industry, having worked for CBC Group and Sonar Pharmaceutical Group Co., Ltd. Mr. FUNG's appointment is for a period of three years. No remuneration will be charged, but expenses may be reimbursed.
Genting Xinyao-B (Genting Xinyao) announces the change of Board of Directors. Mr. Gong Yubo has resigned as a non-executive director on February 9, 2024, without disagreement with the Board's views or other matters to be notified to shareholders and the Exchange. On the same day, Mr. Fung Hong Kong was appointed as the new non-executive director. Mr. Fung has more than 35 years of experience in the medical industry, having worked for CBC Group and Sonar Pharmaceutical Group Co., Ltd. Mr. FUNG's appointment is for a period of three years. No remuneration will be charged, but expenses may be reimbursed.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more